Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call presents a mixed picture. While there is strong organic growth and improved EBITDA margins, the EPS miss and macroeconomic challenges, especially in Nigeria, raise concerns. The strategic disposals and solid liquidity position are positive, but the lack of specific guidance on shareholder returns and potential risks from economic uncertainties balance these out. Given the company's small market cap, these mixed signals are likely to result in a neutral stock price movement, with minor fluctuations expected.
EPS $0.1 EPS, down from expectations of $0.17.
Revenue $271 million, up 5% year-over-year, with organic growth of 26% driven by colocation, lease amendments, new sites, and CPI escalators.
Adjusted EBITDA $253 million, up 36% year-over-year, with a margin of 57.5%, up 1,320 basis points due to cost control and contract resets.
ALFCF $150 million, an increase of 248% year-over-year, driven by improved profitability, low maintenance CapEx, and rephasing of interest payments.
Total CapEx $44 million, down 17.8% year-over-year, due to a narrowed focus on capital allocation.
Consolidated Net Leverage Ratio 3.4x, down from 3.7x at the end of 2024, reflecting improved profitability and cash flow generation.
Liquidity Position Over $900 million of available liquidity at the end of March.
Rwanda Disposal: IHS announced the sale of 100% of IHS Rwanda for an enterprise value of $274.5 million, implying a transaction multiple of 8.3x adjusted EBITDA after leases.
Adjusted EBITDA: Adjusted EBITDA reached $253 million in Q1 2025, with a margin of 57.5%, up 1,320 basis points year-over-year.
ALFCF: ALFCF was $150 million in Q1 2025, an increase of almost 250% year-over-year.
CapEx: Total CapEx was $44 million in Q1 2025, down 17.8% year-over-year.
Strategic Focus: IHS is focusing on financial discipline and capital allocation, aiming to improve profitability and cash flow generation while strengthening the balance sheet.
Earnings Expectations: IHS Holding Limited missed earnings expectations with a reported EPS of $0.1, compared to the expected $0.17.
Currency Devaluation: The company faced challenges due to the devaluation of the Naira, which impacted year-over-year comparisons and revenue.
Regulatory and Economic Factors: The macroeconomic environment in Nigeria remains a concern, with inflation at 24.2% and interest rates steady at 27.5%, which could affect future performance.
Supply Chain Challenges: The company is experiencing supply chain challenges, particularly in relation to the divestitures of towers in Kuwait and Peru, which have impacted revenue and tenant numbers.
Market Focus and Asset Disposals: The strategic decision to dispose of operations in Kuwait, Peru, and Egypt raises concerns about market focus and potential revenue loss from these regions.
Interest Rate Risks: The company is exposed to interest rate risks, particularly with high-interest debt, which could impact cash flow and profitability.
Future Growth Uncertainty: While the company is optimistic about growth opportunities, uncertainties remain regarding the impact of ongoing economic conditions and market dynamics.
Asset Disposal: IHS has agreed to sell 100% of IHS Rwanda for an enterprise value of $274.5 million, implying a transaction multiple of 8.3x adjusted EBITDA after leases.
Focus on Capital Allocation: IHS is narrowing its focus on capital allocation, assessing Group-wide costs and CapEx structures, and introducing technology, including AI, to improve operational efficiencies.
Leverage Reduction: Consolidated net leverage ratio decreased to 3.4x from 3.7x at the end of 2024, reflecting improved profitability and cash flow generation.
2025 Revenue Guidance: IHS maintains its 2025 revenue guidance, expecting growth compared to 2024, excluding the impact of the Kuwait disposal.
Adjusted EBITDA Guidance: IHS expects growth in adjusted EBITDA for 2025, maintaining its outlook.
ALFCF Guidance: IHS anticipates ALFCF for 2025 to be between $350 million to $370 million, with a strong first quarter of $150 million.
Rwanda Disposal Impact: The guidance assumes a full year contribution from Rwanda, but adjustments may be made post-disposal completion in the second half of 2025.
Rwanda Disposal: IHS announced the sale of 100% of IHS Rwanda for an enterprise value of $274.5 million, implying a transaction multiple of 8.3x adjusted EBITDA after leases.
Consolidated Net Leverage Ratio: The consolidated net leverage ratio decreased to 3.4x, down from 3.7x at the end of 2024.
Available Liquidity: IHS reported over $900 million of available liquidity at the end of March 2025.
2025 ALFCF Guidance: IHS expects to generate ALFCF of $350 million to $370 million for the full year 2025.
The earnings call reveals strong revenue growth, particularly in Nigeria and Latin America, and increased EBITDA projections. Guidance has been raised across key financial metrics, indicating confidence in future performance. The Q&A section highlights strategic investments in Brazil and a disciplined capital allocation approach, including potential shareholder returns. Despite some uncertainties in CapEx plans and specific financial strategies, the overall sentiment is positive, supported by growth prospects in 5G and market expansion. Given the company's small market cap, the stock is likely to react positively, with a predicted increase of 2% to 8%.
The earnings call presents a positive outlook: strong revenue growth in key segments, successful debt reduction, and improved financial metrics. The Q&A reveals confidence in leasing activities and strategic asset sales to enhance shareholder value. Although CapEx guidance was lowered, it was due to timing, not performance issues. The market cap suggests a moderate reaction, leading to a positive stock price movement prediction (2% to 8%) over the next two weeks.
The earnings call presents a mixed picture. While there is strong organic growth and improved EBITDA margins, the EPS miss and macroeconomic challenges, especially in Nigeria, raise concerns. The strategic disposals and solid liquidity position are positive, but the lack of specific guidance on shareholder returns and potential risks from economic uncertainties balance these out. Given the company's small market cap, these mixed signals are likely to result in a neutral stock price movement, with minor fluctuations expected.
The earnings call presents a generally positive outlook with strong financial performance, optimistic guidance, and strategic asset sales. The company reported significant revenue and EBITDA growth, reduced CapEx, and improved leverage ratios. The Rwanda disposal and strong liquidity position further reinforce financial health. Despite some regulatory and economic risks, the Q&A session did not reveal significant concerns. With a market cap of $1.1 billion, the stock is likely to react positively to these developments, especially with the strategic focus on asset sales and potential shareholder returns.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.